RBC Capital Reiterates Sector Perform on Bio-Techne, Maintains $86 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated a 'Sector Perform' rating on Bio-Techne (NASDAQ:TECH) and maintained an $86 price target.
September 12, 2023 | 2:52 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RBC Capital has reiterated a 'Sector Perform' rating on Bio-Techne and maintained an $86 price target.
The reiteration of the 'Sector Perform' rating and the maintenance of the $86 price target by RBC Capital indicates that the analyst believes the stock is fairly valued at its current price. This could potentially have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100